Biotech Outsourcing Strategies (BOS) is an established outsourcing focused conference and exhibition for the international Pharmaceutical industry. The event scope is focused on Discovery outsourcing and CMC outsourcing for both small molecules and biologics (primarily development stage).
Catherine Cancian, VP Pharmaceutical Operations, GenSight Biologics, will give an oral presentation on Day 3.
- Title: Designing a Robust CMC Outsourcing Strategy for a Gene Therapy Product and Adapting to Business Interruption Presented by Covid-19
- Day 3 – Biologics CMC Outsourcing Focus
- Session: Outsourcing Perspectives – CMC Biologics Focus
- Date and time: 1st July 2021 – 10:00 – 10:20 (BST)